$BWIN
Baldwin Insurance Group, Inc.

2022 Q1 Form 10-Q Financial Statement

#000178175522000018 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $242.8M $159.2M $152.8M
YoY Change 58.93% 128.74% 181.92%
Cost Of Revenue $153.8M $121.5M $89.40M
YoY Change 71.98% 134.61% 159.13%
Gross Profit $89.10M $37.67M $63.50M
YoY Change 40.31% 111.63% 223.98%
Gross Profit Margin 36.69% 23.66% 41.56%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $988.0K $15.71M $594.0K
YoY Change 66.33% 150.21% 260.0%
% of Gross Profit 1.11% 41.71% 0.94%
Operating Expenses $49.36M $75.55M $27.20M
YoY Change 81.47% 139.09% 88.89%
Operating Profit $39.74M -$37.86M $36.95M
YoY Change 7.55% 175.12% 596.64%
Interest Expense -$10.35M -$8.468M -$5.600M
YoY Change 84.82% 59.77% 833.33%
% of Operating Profit -26.05% -15.16%
Other Income/Expense, Net $5.101M -$6.509M -$5.643M
YoY Change -190.4% 21.1% 864.62%
Pretax Income $44.84M -$44.37M $31.31M
YoY Change 43.22% 131.86% 563.42%
Income Tax $0.00 $19.00K $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $22.87M -$22.65M $15.31M
YoY Change 49.41% 119.7% 942.64%
Net Earnings / Revenue 9.42% -14.23% 10.02%
Basic Earnings Per Share $0.41 -$0.41 $0.35
Diluted Earnings Per Share $0.39 -$0.41 $0.33
COMMON SHARES
Basic Shares Outstanding 55.72M shares 44.26M shares
Diluted Shares Outstanding 58.72M shares 45.78M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.8M $138.3M $90.50M
YoY Change 73.27% 27.46% 73.7%
Cash & Equivalents $156.8M $138.3M $90.54M
Short-Term Investments
Other Short-Term Assets $101.3M $97.60M $36.60M
YoY Change 176.84% 156.83% 415.49%
Inventory
Prepaid Expenses
Receivables $375.3M $340.8M $206.6M
Other Receivables $1.757M $1.668M $0.00
Total Short-Term Assets $635.2M $578.4M $333.8M
YoY Change 90.3% 91.53% 154.95%
LONG-TERM ASSETS
Property, Plant & Equipment $18.28M $17.47M $11.58M
YoY Change 57.9% 58.58% 187.48%
Goodwill $1.232B $1.229B $669.1M
YoY Change 84.18% 88.6% 238.74%
Intangibles $927.6M $944.5M $547.8M
YoY Change 69.35% 70.38% 392.3%
Long-Term Investments
YoY Change
Other Assets $45.54M $25.59M $14.80M
YoY Change 207.83% 130.84% 127.44%
Total Long-Term Assets $2.307B $2.298B $1.252B
YoY Change 84.31% 87.14% 291.95%
TOTAL ASSETS
Total Short-Term Assets $635.2M $578.4M $333.8M
Total Long-Term Assets $2.307B $2.298B $1.252B
Total Assets $2.942B $2.876B $1.585B
YoY Change 85.57% 88.0% 252.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $361.6M $351.9M $33.70M
YoY Change 972.91% 1348.06% 247.42%
Accrued Expenses $13.31M $9.731M $176.7M
YoY Change -92.47% -25.33% 173.11%
Deferred Revenue $22.06M $18.18M $8.308M
YoY Change 165.52% 56.63% 74.32%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.521M $8.521M $4.000M
YoY Change 113.03% 113.03%
Total Short-Term Liabilities $531.3M $540.7M $250.3M
YoY Change 112.23% 148.68% 205.46%
LONG-TERM LIABILITIES
Long-Term Debt $888.2M $849.6M $380.8M
YoY Change 133.24% 122.76% 530.46%
Other Long-Term Liabilities $3.959M $3.590M $2.408M
YoY Change 64.41% 48.41% 19.03%
Total Long-Term Liabilities $3.959M $3.590M $2.408M
YoY Change 64.41% 48.41% 19.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $531.3M $540.7M $250.3M
Total Long-Term Liabilities $3.959M $3.590M $2.408M
Total Liabilities $1.703B $1.689B $814.4M
YoY Change 109.1% 122.22% 316.79%
SHAREHOLDERS EQUITY
Retained Earnings -$32.12M -$54.99M -$9.733M
YoY Change 230.04% 125.88% 35.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $639.4M $608.4M $389.3M
YoY Change
Total Liabilities & Shareholders Equity $2.942B $2.876B $1.577B
YoY Change 86.55% 88.0% 250.26%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $22.87M -$22.65M $15.31M
YoY Change 49.41% 119.7% 942.64%
Depreciation, Depletion And Amortization $988.0K $15.71M $594.0K
YoY Change 66.33% 150.21% 260.0%
Cash From Operating Activities -$3.433M $13.09M $3.287M
YoY Change -204.44% 116.33% -33.88%
INVESTING ACTIVITIES
Capital Expenditures $1.793M -$3.770M $1.000M
YoY Change 79.3% 51.41% 71.53%
Acquisitions $0.00 $17.36M
YoY Change -100.0% -55.84%
Other Investing Activities -$639.0K -$451.1M -$17.36M
YoY Change -96.32% 2.51% -55.84%
Cash From Investing Activities -$3.132M -$454.9M -$18.36M
YoY Change -82.94% 2.78% -53.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $2.127M $1.000M
YoY Change 112.7%
Cash From Financing Activities $22.74M 248.1M -$4.404M
YoY Change -616.26% -52.34% -122.23%
NET CHANGE
Cash From Operating Activities -$3.433M 13.09M $3.287M
Cash From Investing Activities -$3.132M -454.9M -$18.36M
Cash From Financing Activities $22.74M 248.1M -$4.404M
Net Change In Cash $16.17M -193.7M -$19.48M
YoY Change -183.03% -330.54% 28.92%
FREE CASH FLOW
Cash From Operating Activities -$3.433M $13.09M $3.287M
Capital Expenditures $1.793M -$3.770M $1.000M
Free Cash Flow -$5.226M $16.86M $2.287M
YoY Change -328.51% 97.4% -47.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001781755
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39095
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
BRP GROUP, INC.
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1937225
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4211 W. Boy Scout Blvd.
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33607
CY2022Q1 dei City Area Code
CityAreaCode
866
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
279-0698
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
BRP
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54992000 USD
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45543000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
87097000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
89445000 USD
CY2022Q1 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
375290000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156811000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138292000 USD
CY2021Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
340837000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14226000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8151000 USD
CY2022Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1757000 USD
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1668000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
635181000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
578393000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18280000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17474000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83014000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81646000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25586000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
927605000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
35088000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
944467000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1232399000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1228741000 USD
CY2022Q1 us-gaap Assets
Assets
2942022000 USD
CY2021Q4 us-gaap Assets
Assets
2876307000 USD
CY2022Q1 brp Premiums Payable To Insurance Companies
PremiumsPayableToInsuranceCompanies
309257000 USD
CY2021Q4 brp Premiums Payable To Insurance Companies
PremiumsPayableToInsuranceCompanies
310045000 USD
CY2022Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
52314000 USD
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
41833000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87316000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
92223000 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
61500000 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
61500000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
20897000 USD
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
35000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
540689000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
531284000 USD
CY2022Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
75000000 USD
CY2022Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
813172000 USD
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
814614000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
206950000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
223501000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
72622000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71357000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3959000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3590000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1702987000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1688751000 USD
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
288000 USD
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
269000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
671143000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
663002000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32123000 USD
CY2022Q1 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
175000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
639439000 USD
CY2021Q4 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
219000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
594000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
608383000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
599308000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
578904000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1238747000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1187287000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2942022000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2876307000 USD
CY2022Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
242848000 USD
CY2021Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
152828000 USD
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
153750000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
89375000 USD
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
36442000 USD
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
16875000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17562000 USD
CY2021Q1 brp Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset And Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetAndLiability
-1503000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
988000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
203110000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
115878000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10537000 USD
CY2022Q1 brp Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset And Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetAndLiability
-5632000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
39738000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36950000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10350000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5643000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15451000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5101000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5643000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
44839000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
31307000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21970000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
44839000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
31307000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16001000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
22869000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15306000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
21970000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
16001000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22869000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15306000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55719803 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44255011 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58715825 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45783086 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1187287000 USD
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
44820000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6596000 USD
CY2022Q1 brp Reduction Of Stockholders Notes Payable To Member Units
ReductionOfStockholdersNotesPayableToMemberUnits
44000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
11131000 USD
CY2022Q1 brp Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset And Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetAndLiability
-5632000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1238747000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
769870000 USD
CY2021Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
31280000 USD
CY2021Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
2459000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2489000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
CY2021Q1 brp Reduction Of Stockholders Notes Payable To Member Units
ReductionOfStockholdersNotesPayableToMemberUnits
116000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
806214000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
44839000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
31307000 USD
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
18550000 USD
CY2021Q1 brp Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset And Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetAndLiability
-1503000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7564000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3542000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1286000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
693000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
627000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
15810000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 USD
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
11117000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
CY2022Q1 us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
35359000 USD
CY2021Q1 us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
50364000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8908000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
467000 USD
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
89000 USD
CY2021Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-174000 USD
CY2022Q1 brp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
1368000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3433000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3287000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7751000 USD
CY2021Q1 brp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
54856000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1984000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
55879000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1793000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000000 USD
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
639000 USD
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2022Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
700000 USD
CY2021Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
17358000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3132000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18358000 USD
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
13993000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
40000000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2127000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1188000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
59000 USD
CY2022Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 USD
CY2021Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
3461000 USD
CY2022Q1 brp Proceeds From Collection Of Stock Subscription Receivable
ProceedsFromCollectionOfStockSubscriptionReceivable
44000 USD
CY2021Q1 brp Proceeds From Collection Of Stock Subscription Receivable
ProceedsFromCollectionOfStockSubscriptionReceivable
116000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22736000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4404000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16171000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19475000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227737000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36950000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142022000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243908000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122547000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
9049000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
5765000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5336000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2022Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
3658000 USD
CY2021Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0 USD
CY2022Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
92000 USD
CY2021Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2022Q1 brp Business Combination Consideration Transferred Liabilities Incurred Contingent Earnout
BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentEarnout
0 USD
CY2021Q1 brp Business Combination Consideration Transferred Liabilities Incurred Contingent Earnout
BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentEarnout
6711000 USD
CY2022Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0 USD
CY2021Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
2459000 USD
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
244000 USD
CY2022Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-07-01
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates underlying the accompanying consolidated financial statements include the application of guidance for revenue recognition, including determination of allowances for estimated policy cancellations; the determination of fair value in relation to business combinations, purchase price allocation and valuation of intangible assets and contingent consideration; impairment of long-lived assets including goodwill; valuation of the Tax Receivable Agreement liability and income taxes; and share-based compensation.
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
16875000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
115878000 USD
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2021Q1 us-gaap Profit Loss
ProfitLoss
31307000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
31307000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15306000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
467000 USD
CY2021Q1 brp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
54856000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7751000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
55879000 USD
CY2022Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
242848000 USD
CY2021Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
152828000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P5Y
CY2022Q1 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
206193000 USD
CY2021Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
168550000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22059000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18178000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14200000 USD
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
11336000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
4751000 USD
CY2021Q4 brp Distributions Under Tax Receivable Agreement Payable
DistributionsUnderTaxReceivableAgreementPayable
5072000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5245000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3386000 USD
CY2022Q1 brp Capitalized Contract Cost Capitalized Amount
CapitalizedContractCostCapitalizedAmount
3630000 USD
CY2021Q1 brp Capitalized Contract Cost Capitalized Amount
CapitalizedContractCostCapitalizedAmount
835000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
927000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
422000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
14039000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
5164000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22059000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18178000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13310000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9731000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13239000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12520000 USD
CY2022Q1 brp Deferred Consideration Payments
DeferredConsiderationPayments
9941000 USD
CY2021Q4 brp Deferred Consideration Payments
DeferredConsiderationPayments
12355000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8521000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8521000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9929000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22460000 USD
CY2022Q1 brp Distributions Under Tax Receivable Agreement Payable
DistributionsUnderTaxReceivableAgreementPayable
5072000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87316000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
92223000 USD
CY2022Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
61500000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3215731 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
28.83
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
339268 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.13
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
190476 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
29.36
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
28035 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
25.54
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3336488 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.39
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7600000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22869000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15306000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55720000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44255000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22869000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
15306000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55720000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44255000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2996000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1528000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58716000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45783000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5600000 USD
CY2022Q1 brp Business Combination And Assets Acquisitions Contingent Consideration Arrangements Liabilities Rangeof Outcomes Value High
BusinessCombinationAndAssetsAcquisitionsContingentConsiderationArrangementsLiabilitiesRangeofOutcomesValueHigh
1000000000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
22800000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
23500000 USD
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segment
CY2022Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
242848000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
44839000 USD
CY2021Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
152828000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
31307000 USD
CY2022Q1 us-gaap Assets
Assets
2942022000 USD
CY2021Q4 us-gaap Assets
Assets
2876307000 USD

Files In Submission

Name View Source Status
0001781755-22-000018-index-headers.html Edgar Link pending
0001781755-22-000018-index.html Edgar Link pending
0001781755-22-000018.txt Edgar Link pending
0001781755-22-000018-xbrl.zip Edgar Link pending
brp-20220331.htm Edgar Link pending
brp-20220331.xsd Edgar Link pending
brp-20220331_cal.xml Edgar Link unprocessable
brp-20220331_def.xml Edgar Link unprocessable
brp-20220331_g1.jpg Edgar Link pending
brp-20220331_htm.xml Edgar Link completed
brp-20220331_lab.xml Edgar Link unprocessable
brp-20220331_pre.xml Edgar Link unprocessable
exhibit-311fy2022q1.htm Edgar Link pending
exhibit-312fy2022q1.htm Edgar Link pending
exhibit-32fy2022q1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending